logo
welcome
Reuters

Reuters

Consumer groups ask FTC to block Novo Holdings-Catalent deal

Reuters
Summary
Nutrition label

81% Informative

Five U.S. consumer groups and two large labor unions urge FTC to block $16.5 billion deal.

They say deal threatens competition in weight loss drugs and cutting-edge gene therapies.

Novo Holdings has said it would boost supply of Wegovy, Novo's blockbuster GLP-1 injectable weight loss drug.

VR Score

90

Informative language

96

Neutral language

66

Article tone

formal

Language

English

Language complexity

68

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links